Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
COPENHAGEN, Denmark, November 23, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 410,610 as a consequence of employees’ exercise of warrants.
The capital increase was effected without any pre-emption rights for the existing shareholders of the Company or others. A total of 41,061 new shares were subscribed for in cash at DKK 142.00 per share of nominally DKK 10. The total proceeds to Bavarian Nordic A/S from the capital increase amounts to DKK 5.8 million.
The new shares, which will rank pari passu in all respects with existing Bavarian Nordic shares, will be admitted to trading and official listing on Nasdaq Copenhagen as soon as possible.
After the capital increase, the total nominal value of Bavarian Nordic A/S' share capital is DKK 707,353,760, which is made up of 70,735,376 shares of a nominal value of DKK 10 each, corresponding to 70,735,376 votes.
The revised Articles of Association will be published separately and will subsequently be available on the Company's website.
The content of this announcement does not affect the Company’s expectations for the financial results for 2022.
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against monkeypox. The vaccine is also approved in Europe and Canada. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, email@example.com, Tel: +1 781 686 9600
Company Announcement no. 41 / 2022
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
RCI Banque - Press release: THE BOARD OF DIRECTORS OF RCI BANQUE SA APPOINTS PATRICK CLAUDE AS ACTING CHAIRMAN OF THE BOARD OF DIRECTORS OF RCI BANQUE SA7.12.2022 18:39:35 CET | Press release
PRESS RELEASE December 7th 2022 THE BOARD OF DIRECTORS OF RCI BANQUE SA APPOINTS PATRICK CLAUDE AS ACTING CHAIRMAN OF THE BOARD OF DIRECTORS OF RCI BANQUE SA The Nominations Committee of RCI Banque SA acknowledged the resignation of Clotilde Delbos as of December 31, 2022. Patrick Claude, VP Finance of Renault Group and member of the board of RCI Banque SA, has been proposed as acting Chairman of the Board of Directors of RCI Banque SA from January 1, 2023. The Board of Directors of RCI Banque SA, met on December 7 and very warmly thanked Clotilde Delbos her role as Chairman. The Board approved the appointment of Patrick Claude as acting Chairman of the Board of Directors of RCI Banque SA. Patrick Claude was also appointed as acting member of the Nominations Committee and the Remuneration Committee. The appointment of Patrick Claude as acting Chairman of the Board of Directors of RCI Banque SA will be subject to the approval of the European Central Bank. Patrick Claude is a graduate of
Ress Life Investments A/S publishes annual report7.12.2022 18:09:31 CET | Press release
Ress Life Investments A/S Corporate Announcement no. 44/2022 Annual Report 2021/22 http://www.resslifeinvestments.com/ CorporateAnnouncementno.44/2022:AnnualReport1October2021–30 September2022 Copenhagen, 7 December 2022 The Board of Directors and Management have today discussed and approved the Annual Report of Ress Life Investments A/S for the period 1 October 2021 – 30 September 2022. Key results and highlights: Ress Life Investments A/S realised a net profit before and after tax of USD 34,895,871 for the period 1 October 2021 – 30 September 2022. Net profit for the period corresponds to a net return on equity of 10.5% and an increase in net asset value of USD 229 per share. The increase in profit mainly relates to pay-outs of policies offset by administrative expenses and staff costs. The fair value of the Group’s investment assets increased from USD 255,262,257 at 30 September 2021 to USD 303,228,365 at 30 September 2022. The Group’s investments in treasury bills increased from US
PRESS RELEASE NACON: Ishtar Games, NACON’s indie label, announces new publishing line-up:7.12.2022 18:00:00 CET | Press release
Ishtar Games, NACON’s indie label, announces new publishing line-up After 17 years of developing games, Ishtar Games now also provides dedicated and passionate publishing support to its first group of studio partners. Lille, France, December 7th, 2022 — NACON is pleased to announce that its studio and indie-publishing label, Ishtar Games, developer behind Dead in Vinland, The Last Spell, reveals today the first games they will publish: Worlds of Aria (Ludogram Games), Spirited Thief (Koi Snowman Games), and their own developed game Lakeburg Legacies, all releasing in 2023. Take a look at the first line-up reveal trailer: https://youtu.be/7OpVbH7Rq-o "We are super excited to initiate our indie publishing label’s journey with Koi Snowman and Ludogram," Ishtar Games CEO and Creative Director Matthieu Richez said. "They have brought to us not only excellent games, but also great human beings to work with. I am convinced that this collaboration will bear fruit for all parties involved, whic
Ilkka Oyj – Acquisition of own shares on 7 December 20227.12.2022 18:00:00 CET | Press release
ILKKA OYJ, STOCK EXCHANGE RELEASE, 7 December 2022 at 19:00 EET IlkkaOyj – Acquisition of own shares on 7 December 2022 At Nasdaq Helsinki Ltd: Date7 December 2022Exchange transactionBuyShare trading codeILKKA2Amount, shares 1,350Average price/share, EUR3.6969Total cost, EUR4,990.82 The company holds a total of 2,917 of its own shares (ILKKA2) including the shares acquired on 7 December 2022. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.com Attachment Ilkka buyback 7.12.2022
Rovio Entertainment Corporation: Repurchase of own shares on 7 December 20227.12.2022 17:45:00 CET | Press release
Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 7.12.2022 at 18.45 EETRovio Entertainment Corporation - Repurchase of own shares on 7.12.2022Rovio Entertainment CorporationIn the Nasdaq HelsinkiDate7.12.2022Exchange transactionBUYShare trading codeROVIOAmount, shares32063Average price/share, EUR6,023788Total cost, EUR193140,71Rovio now holds a total of 6 548 427 shares including the shares repurchased on 7.12.2022On behalf of Rovio Entertainment CorporationOP Corporate Bank PLC Further information: Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution: Nasdaq Helsinki Ltd Key media www.rovio.com About Rovio: Rovio Entertainment Corporation is a global mobile-first games company that creates, develops and publishes mobile games, which have been downloaded over 5 billion times. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainment, a